In order to better define the immune-modulatory properties of the tested strains, we also evaluated whether CFS would modulate the expression of IL-10 and IL-12, i.e. two immune mediators with regulatory, anti-inflammatory and pro-inflammatory action, respectively. This evidence concerns the gene IL10 and myalgic encephalomeyelitis/chronic fatigue syndrome.